NICE Updates UK Guidelines for Lokelma in CKD-HK
The National Institute of Health and Care Excellence (NICE) has updated its guideline for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate)…
By
Denis Ilinov
All Articles
Revealed: pharma leaders in precision, personalised medicine
GlobalData’s Thematic Research ecosystem ranks companies on a scale of 1 to 5 based on their likelihood to tackle…
By
FDA issues complete response letter for Merck’s chronic cough treatment
The regulatory agency sought further data linked to the measurement of efficacy.
FDA limits usage of Lilly and Regeneron’s monoclonal antibodies for Covid-19
The move comes after data showed these therapies are highly unlikely to be active against the Omicron variant.
Virtual Care and Telemedicine: Healthcare and medical device trends
The virtual care space includes a rich ecosystem of players across the telehealth and remote patient monitoring segments. Telehealth…
Novavax Covid-19 vaccine to be rolled out in Australia from next month
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
By
Antibacterial resistance needs a global-scale response like Covid-19
On January 19, The Lancet published the paper ‘Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis’.…
By
FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis
The FDA approval is based on data from two Skyrizi Phase III trials, KEEPsAKE-1 and KEEPsAKE-2.